What is the treatment for self-inflicted lung injury?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Patient Self-Inflicted Lung Injury (P-SILI): Definition and Treatment

Patient self-inflicted lung injury (P-SILI) is a life-threatening condition where excessive respiratory effort in patients with acute lung injury paradoxically worsens lung damage through mechanisms including excessive transpulmonary pressure, pendelluft, cyclic alveolar recruitment/derecruitment, and increased pulmonary edema—requiring early recognition and aggressive respiratory support modulation to prevent progression. 1, 2

Pathophysiology

P-SILI develops when patients with injured lungs generate vigorous inspiratory efforts that cause additional lung damage through several mechanisms 1, 3:

  • Excessive transpulmonary pressure creates over-distension and volutrauma in already compromised lung tissue 1, 2
  • Inhomogeneous pressure distribution leads to cyclic opening/closing of non-dependent lung regions and pendelluft phenomenon (gas movement between lung regions with different time constants) 1
  • Increased transvascular pressure aggravates pulmonary edema by promoting fluid extravasation 1
  • Vicious cycle formation occurs as worsening gas exchange and respiratory mechanics further increase respiratory drive and effort 4

This can occur both during spontaneous breathing and during mechanical ventilation with preserved spontaneous respiratory activity 2.

Clinical Recognition

High-Risk Populations

Patients at highest risk include those with 5, 3:

  • Acute respiratory distress syndrome (ARDS)
  • Severe hypoxemic acute respiratory failure
  • High respiratory drive from hypoxemia or metabolic acidosis
  • Failed noninvasive ventilation attempts

Clinical Signs of Dangerous Respiratory Effort

Monitor for these bedside indicators of potentially injurious effort 2, 3:

  • Visible signs of increased work of breathing: accessory muscle use, paradoxical abdominal motion, tracheal tug, nasal flaring 2
  • Tachypnea (respiratory rate >30-35 breaths/minute) 2
  • Progressive hypoxemia despite adequate initial ventilatory parameters 5
  • Worsening respiratory system mechanics during spontaneous breathing trials 5
  • Radiographic deterioration correlating with spontaneous breathing periods 5

Objective Monitoring Parameters

Several non-invasive methods correlate with excessive respiratory muscle pressure 2:

  • Esophageal pressure monitoring (gold standard but invasive)
  • Airway occlusion pressure (P0.1)
  • Diaphragm ultrasound showing excessive thickening fraction
  • High driving pressure during assisted ventilation

Critical caveat: Conventional monitoring variables may be insufficient to predict P-SILI development, as demonstrated in case reports where patients deteriorated despite "adequate" initial parameters 5.

Treatment Strategy

Immediate Management for Suspected P-SILI

The primary goal is to reduce excessive respiratory effort while maintaining adequate gas exchange 1, 2:

  1. Optimize sedation and analgesia to reduce respiratory drive 2, 3

    • Titrate sedatives to achieve controlled, less vigorous breathing
    • Consider deeper sedation if signs of injurious effort persist
  2. Adjust ventilator settings 2:

    • Increase pressure support to reduce patient effort
    • Apply adequate PEEP to prevent cyclic recruitment/derecruitment
    • Consider switching from pressure support to controlled modes if effort remains excessive
  3. Consider neuromuscular blockade in severe cases where sedation alone fails to control dangerous respiratory effort 2, 3

  4. Prone positioning may reduce respiratory drive by improving oxygenation 3

Ventilation Strategy

Use lung-protective ventilation principles 6:

  • Low tidal volume (<6 mL/kg predicted body weight) to minimize volutrauma 6
  • Moderate PEEP to prevent atelectrauma and maintain alveolar recruitment 6
  • Avoid hyperventilation: target PaCO₂ 5.0-5.5 kPa (38-41 mmHg) as hypocapnia worsens outcomes through cerebral vasoconstriction and metabolic derangements 6
  • Limit plateau pressure to prevent overdistension 6

Decision Algorithm for Intubation vs. Continued Spontaneous Breathing

Early intubation is indicated when 2, 5:

  • Clinical signs of excessive work of breathing persist despite optimization
  • Progressive hypoxemia develops during spontaneous breathing trials
  • Radiographic deterioration correlates with spontaneous breathing periods
  • Patient fails to tolerate partial ventilatory support after multiple attempts

Delayed intubation in P-SILI is associated with higher mortality 5, 3, making early recognition critical.

Weaning Considerations

Approach spontaneous breathing trials cautiously 5:

  • Ensure underlying lung injury has substantially improved before attempting spontaneous breathing
  • Monitor closely for signs of P-SILI recurrence during each trial
  • Be prepared to return to controlled ventilation if deterioration occurs
  • Failure to assume spontaneous breathing after multiple attempts carries poor prognosis 5

Critical Pitfalls

  • Assuming adequate initial parameters guarantee safe spontaneous breathing: Patients can deteriorate rapidly despite initially acceptable settings 5
  • Delaying intubation in patients with obvious excessive effort: This increases mortality risk 3
  • Relying solely on conventional monitoring: Advanced monitoring may be needed to detect injurious effort 5, 4
  • Premature weaning attempts: Ensure substantial lung healing before transitioning to spontaneous modes 5

Evidence Limitations

Important caveat: No clinical study has yet demonstrated that ventilatory strategies specifically targeting P-SILI prevention improve outcomes, though the concept relies on sound physiological reasoning, clinical observations, and experimental data 1, 4. Further research is needed to establish optimal identification and prevention strategies 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.